BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8776736)

  • 1. Mutational analyses of the extracellular domain of the full-length lutropin/choriogonadotropin receptor suggest leucine-rich repeats 1-6 are involved in hormone binding.
    Thomas D; Rozell TG; Liu X; Segaloff DL
    Mol Endocrinol; 1996 Jun; 10(6):760-8. PubMed ID: 8776736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletions of portions of the extracellular loops of the lutropin/choriogonadotropin receptor decrease the binding affinity for ovine luteinizing hormone, but not human choriogonadotropin, by preventing the formation of mature cell surface receptor.
    Abell A; Liu X; Segaloff DL
    J Biol Chem; 1996 Feb; 271(8):4518-27. PubMed ID: 8626807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not of the lutropin/choriogonadotropin receptor.
    Rozzell TG; Wang H; Liu X; Segaloff DL
    Mol Endocrinol; 1995 Dec; 9(12):1727-36. PubMed ID: 8614409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone-binding properties and glycosylation pattern of a recombinant form of the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor expressed in mammalian cells.
    Thomas DM; Segaloff DL
    Endocrinology; 1994 Nov; 135(5):1902-12. PubMed ID: 7956911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential binding affinities of the luteinizing hormone (LH)/choriogonadotropin receptor for LH and choriogonadotropin are dictated by different extracellular domain residues.
    Galet C; Ascoli M
    Mol Endocrinol; 2005 May; 19(5):1263-76. PubMed ID: 15677709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling.
    Bhowmick N; Huang J; Puett D; Isaacs NW; Lapthorn AJ
    Mol Endocrinol; 1996 Sep; 10(9):1147-59. PubMed ID: 8885249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The six N-linked carbohydrates of the lutropin/choriogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding, or signal transduction.
    Davis DP; Rozell TG; Liu X; Segaloff DL
    Mol Endocrinol; 1997 May; 11(5):550-62. PubMed ID: 9139799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of truncations of the cytoplasmic tail of the luteinizing hormone/chorionic gonadotropin receptor on receptor-mediated hormone internalization.
    Rodriguez MC; Xie YB; Wang H; Collison K; Segaloff DL
    Mol Endocrinol; 1992 Mar; 6(3):327-36. PubMed ID: 1316539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfected cells express mostly the intracellular precursor of the lutropin/choriogonadotropin receptor but this precursor binds choriogonadotropin with high affinity.
    Fabritz J; Ryan S; Ascoli M
    Biochemistry; 1998 Jan; 37(2):664-72. PubMed ID: 9425089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive cytoplasmic tail truncations of the lutropin-choriogonadotropin receptor prevent agonist- or phorbol ester-induced phosphorylation, impair agonist- or phorbol ester-induced desensitization, and enhance agonist-induced receptor down-regulation.
    Wang Z; Hipkin RW; Ascoli M
    Mol Endocrinol; 1996 Jun; 10(6):748-59. PubMed ID: 8776735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of the lutropin/choriogonadotropin receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of the bound hormone.
    Wang Z; Liu X; Ascoli M
    Mol Endocrinol; 1997 Feb; 11(2):183-92. PubMed ID: 9013765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two mutations of the lutropin/choriogonadotropin receptor that impair signal transduction also interfere with receptor-mediated endocytosis.
    Dhanwada KR; Vijapurkar U; Ascoli M
    Mol Endocrinol; 1996 May; 10(5):544-54. PubMed ID: 8732685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite contribution of two ligand-selective determinants in the N-terminal hormone-binding exodomain of human gonadotropin receptors.
    Vischer HF; Granneman JC; Bogerd J
    Mol Endocrinol; 2003 Oct; 17(10):1972-81. PubMed ID: 12869592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dileucine-based motif in the C-terminal tail of the lutropin/choriogonadotropin receptor inhibits endocytosis of the agonist-receptor complex.
    Nakamura K; Ascoli M
    Mol Pharmacol; 1999 Oct; 56(4):728-36. PubMed ID: 10496955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lutropins appear to contact two independent sites in the extracellular domain of their receptors.
    Bernard MP; Myers RV; Moyle WR
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):611-7. PubMed ID: 9794802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the Lutropin/Choriogonadotropin receptor.
    Min KS; Liu X; Fabritz J; Jaquette J; Abell AN; Ascoli M
    J Biol Chem; 1998 Dec; 273(52):34911-9. PubMed ID: 9857020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
    Alvarez CA; Narayan P; Huang J; Puett D
    Endocrinology; 1999 Apr; 140(4):1775-82. PubMed ID: 10098515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of the binding affinity of the luteinizing hormone/choriogonadotropin receptor by sodium ions is mediated by a highly conserved aspartate located in the second transmembrane domain of G protein-coupled receptors.
    Quintana J; Wang H; Ascoli M
    Mol Endocrinol; 1993 Jun; 7(6):767-75. PubMed ID: 8395653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive charges in a putative amphiphilic helix in the carboxyl-terminal region of the third intracellular loop of the luteinizing hormone/chorionic gonadotropin receptor are not required for hormone-stimulated cAMP production but are necessary for expression of the receptor at the plasma membrane.
    Wang H; Jaquette J; Collison K; Segaloff DL
    Mol Endocrinol; 1993 Nov; 7(11):1437-44. PubMed ID: 8114758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of transmembrane helix 7 in the activation of the heptahelical lutropin receptor.
    Angelova K; Narayan P; Simon JP; Puett D
    Mol Endocrinol; 2000 Apr; 14(4):459-71. PubMed ID: 10770485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.